Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Canafax

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|April 1, 1996
Neoral cyclosporineD M Canafax
Clinical Transplantation|February 1, 1995
Minimizing cyclosporine concentration variability to optimize transplant outcomeD M Canafax
Therapeutic Drug Monitoring|January 1, 1984
Cyclosporine: experience with therapeutic monitoringL D Bowers, D M Canafax
Pharmacotherapy|January 1, 1987
Monoclonal antilymphocyte antibody (OKT3) treatment of acute renal allograft rejectionD M Canafax, C A Draxler
Pharmacotherapy|January 1, 1987
Recent advances in solid organ transplantationD M Canafax, D E Sutherland
Seminars in Respiratory Infections|June 1, 1991
Antimicrobial treatment of otitis mediaG S Giebink, D M Canafax
The Journal of Antimicrobial Chemotherapy|October 1, 1995
Important interactions of drugs with immunosuppressive agents used in transplant recipientsK D Lake, D M Canafax
Transplantation Proceedings|August 1, 1996
Cyclosporine pharmacologyJ I Lee, D M Canafax
The Annals of Otology, Rhinology & Laryngology. Supplement|May 1, 1994
Antimicrobial treatment of acute otitis mediaD M Canafax, G S Giebink
Advances in Pediatric Infectious Diseases|January 1, 1988
Controversies in the management of acute otitis mediaG S Giebink, D M Canafax
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|April 1, 1996
Neoral cyclosporineD M Canafax
Clinical Transplantation|February 1, 1995
Minimizing cyclosporine concentration variability to optimize transplant outcomeD M Canafax
Therapeutic Drug Monitoring|January 1, 1984
Cyclosporine: experience with therapeutic monitoringL D Bowers, D M Canafax
Pharmacotherapy|January 1, 1987
Monoclonal antilymphocyte antibody (OKT3) treatment of acute renal allograft rejectionD M Canafax, C A Draxler
Pharmacotherapy|January 1, 1987
Recent advances in solid organ transplantationD M Canafax, D E Sutherland
Seminars in Respiratory Infections|June 1, 1991
Antimicrobial treatment of otitis mediaG S Giebink, D M Canafax
The Journal of Antimicrobial Chemotherapy|October 1, 1995
Important interactions of drugs with immunosuppressive agents used in transplant recipientsK D Lake, D M Canafax
Transplantation Proceedings|August 1, 1996
Cyclosporine pharmacologyJ I Lee, D M Canafax
The Annals of Otology, Rhinology & Laryngology. Supplement|May 1, 1994
Antimicrobial treatment of acute otitis mediaD M Canafax, G S Giebink
Advances in Pediatric Infectious Diseases|January 1, 1988
Controversies in the management of acute otitis mediaG S Giebink, D M Canafax
Pageof 11